Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4
SG Meuth, A Bayas, B Kallmann, R Linker… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Oral cladribine is a highly effective pulsed selective immune reconstitution
therapy licensed for relapsing multiple sclerosis (RMS) since 2017. A full treatment course …
therapy licensed for relapsing multiple sclerosis (RMS) since 2017. A full treatment course …
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
F Dominelli, MA Zingaropoli, M Tartaglia… - Frontiers in …, 2022 - frontiersin.org
Background The mRNA vaccines help protect from COVID-19 severity, however multiple
sclerosis (MS) disease modifying therapies (DMTs) might affect the development of humoral …
sclerosis (MS) disease modifying therapies (DMTs) might affect the development of humoral …
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different …
Background The decline of humoral response to COVID-19 vaccine led to authorise a
booster dose. Here, we characterised the kinetics of B-cell and T-cell immune responses in …
booster dose. Here, we characterised the kinetics of B-cell and T-cell immune responses in …
Dynamic evolution of humoral and T-cell specific immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis followed until the booster dose
This study characterizes antibody and T-cell immune responses over time until the booster
dose of COronaVIrus Disease 2019 (COVID-19) vaccines in patients with multiple sclerosis …
dose of COronaVIrus Disease 2019 (COVID-19) vaccines in patients with multiple sclerosis …
Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study
Y Yang, X Li, X Zhao, Y Liu, T Zhao, Q Zhu - Clinics and Research in …, 2023 - Elsevier
Patients with chronic liver disease (CLD) are at a greater risk of severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) infection. This study investigated the antibody …
syndrome coronavirus type 2 (SARS-CoV-2) infection. This study investigated the antibody …
[图书][B] Multiple sclerosis, viruses, and B cell depleting therapy: a meeting at the immune system
K Asplund Högelin - 2024 - openarchive.ki.se
Multiple sclerosis (MS) is a highly heterogeneous disease with a complex and undiscovered
etiology. Two of the strongest established risk factors for developing MS are carriage of the …
etiology. Two of the strongest established risk factors for developing MS are carriage of the …
Cladribine Tablets: A Review of the Practical Considerations in Multiple Sclerosis Nursing Practice.
D Thomas, N Barker, W Brownlee… - touchREVIEWS in …, 2022 - search.ebscohost.com
Nurses specializing in the care of patients with multiple sclerosis (MS) are uniquely
positioned to provide personalized care. Patients prescribed cladribine tablets (taken for= 10 …
positioned to provide personalized care. Patients prescribed cladribine tablets (taken for= 10 …